Search Results 871-880 of 19970 for Hepatitis C

1. A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease - Mayo Clinic

   ... hepatitis B or hepatitis C at screening. History of acute/chronic hepatitis B or C and/or carriers of hepatitis B (seropositive for hepatitis B surface ...

2. Surgery - Doctors - Mayo Clinic

   ... Hepatitis C, Hepatitis B, No...nalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Wilson's ...

3. Liver transplant - Doctors & Departments - Mayo Clinic

   Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

4. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Positive hepatitis C antibody test result or positive hepatitis C ... Hepatitis C RNA test is obtained. Participating Mayo Clinic locations. Study statuses ...

5. Immune globulin (intramuscular route, intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

   Description. Immune globulin injection is used to prevent infections or make the infection less severe (eg, hepatitis A with not more than 2 weeks of exposure, ...

6. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   - Seropositivity for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after completion of ...

7. IgA nephropathy (Berger disease) - Symptoms and causes - Mayo Clinic

   Liver diseases. These include scarring of the liver called cirrhosis and chronic hepatitis B and C infections. Celiac disease. Eating gluten, a protein found in ...

8. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

   ... hepatitis B core antigen (anti-HBc), and/or anti-hepatitis C virus (anti-HCV). Antiviral therapy per local standard-of-care if active hepatitis B virus (HBV).

9. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   - Positive hepatitis C antibody test result or positive hepatitis C ribonucleic acid (RNA) test result at screening - NOTE: Subjects with positive hepatitis ...

10. Publications - Rozalina G. McCoy, M.D., M.S. - Mayo Clinic

    ... Hepatitis C Virus Infection. JAMA Netw Open. 2022 Mar 1; 5 (3):e2142282 Epub 2022 Mar 01. View PubMed; Dunlay SM, Killian JM, Mccoy RG, Redfield MM. Diabetes ...